Case-orientated approach to the management of hepatocellular adenoma

British Journal of Surgery

Volumn 93, Issue 12, 2006, Pages 1495-1502

  Van Der Windt, D J ^a   Kok, N F M ^a   Hussain, S M ^a,b   Zondervan, P E ^a   Alwayn, I P J ^a   De Man, R A ^a   Ijzermans, J N M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FATTY LIVER; FEMALE; HUMAN; INVASIVE PROCEDURE; LIVER ADENOMA; LIVER SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VOLUME;

ADENOMA, LIVER CELL; ADULT; CONTRACEPTIVES, ORAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845387114     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5511     Document Type: Article

References (30)

1. Reddy KR, Schiff ER. Approach to a liver mass. Semin Liver Dis 1993; 13: 423-435.
2. Baum JK, Bookstein JJ, Holtz F, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet 1973; 2: 926-929.
3. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979; 242: 644-648.
4. Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg 1994; 129: 712-717.
5. Perret AG, Mosnier JF, Porcheron J, Cuilleron M, Berthoux P, Boucheron S et al. Role of oral contraceptives in the growth of a multilobular adenoma associated with a hepatocellular carcinoma in a young woman. J Hepatol 1996; 25: 976-979.
6. Ault GT, Wren SM, Rails PW, Reynolds TB, Stain SC. Selective management of hepatic adenomas. Am Surg 1996; 62: 825-829.
7. Chiche L, Dao T, Salame E, Galais MP, Bouvard N, Schmutz G et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 2000; 231: 74-81.
8. Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW et al. Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001; 136: 1033-1038.
9. Charny CK, Jarnagin WR, Schwartz LH, Frommeyer HS, DeMatteo RP, Fong Y et al. Management of 155 patients with benign liver tumours. Br J Surg 2001; 88: 808-813.
10. Choi BY, Nguyen MH. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 2005; 39: 401-412.
11. de Rave S, Hussain SM. A liver tumour as an incidental finding: differential diagnosis and treatment. Scand J Gastroenterol Suppl 2002; 37: 81-86.
12. Descottes B, Glineur D, Lachachi F, Valleix D, Paineau J, Hamy A et al. Laparoscopic liver resection of benign liver tumors. Surg Endosc 2003; 17: 23-30.
13. Ichikawa T, Federle MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 2000; 214: 861-868.
14. Numminen K, Halavaara J, Tervahartiala P, Isoniemi H, Kivisaari L, Palomaki M et al. Liver tumour MRI: what do we need for lesion characterization? Scand J Gastroenterol 2004; 39: 67-73.
15. Hussain SM, Semelka RC. Hepatic imaging: comparison of modalities. Radiol Clin North Am 2005; 43: 929-947.
16. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Metreau JM, Meignan M et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995; 22: 1674-1681.
17. Closset J, Veys I, Peny MO, Braude P, Van Gansbeke D, Lambilliotte JP et al. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. Hepatogastroenterology 2000; 47: 1382-1384.
18. Kim J, Ahmad SA, Lowy AM, Buell JF, Pennington LJ, Moulton JS et al. An algorithm for the accurate identification of benign liver lesions. Am J Surg 2004; 187: 274-279.
19. Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988; 208: 558-564.
20. Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997; 21: 983-990; discussion 990-991.
21. Buhler H, Pirovino M, Akobiantz A, Altorfer J, Weitzel M, Maranta E et al. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982; 82: 775-782.
22. Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. Radiographics 2001; 21: 877-892; discussion 892-894.
23. Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, de Man RA, Krestin GP. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 2002; 22: 1023-1036; discussion 1037-1039.
24. Bioulac-Sage P, Rebouissou S, Sa Cunha A, Jeannot E, Lepreux S, Blanc JF et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005; 128: 1211-1218.
25. Paradis V, Benzekri A, Dargere D, Bieche I, Laurendeau I, Vilgrain V et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 2004; 126: 1323-1329.
26. Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985; 89: 1132-1138.
27. Hung CH, Changchien CS, Lu SN, Eng HL, Wang JH, Lee CM et al. Sonographic features of hepatic adenomas with pathologic correlation. Abdom Imaging 2001; 26: 500-506.
28. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998; 2: 292-298.
29. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191: 38-46.
30. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003; 7: 1034-1044.